Hiv-1 Protease
Construction of a Human Immunodeficiency Virus Type 1 (HIV-1) Library Containing Random Combinations of Amino Acid Substitutions in the HIV-1 Protease due to Resistance by Protease Inhibitors
7
Design and synthesis of inhibitors for the HIV 1 protease
161
HIV-1 Protease-Substrate Coevolution in Nelfinavir Resistance
10
Docking Studies of HIV 1 Protease with Phytochemicals from Mappia foetida
7
HIV-1 Protease, Reverse Transcriptase, and Integrase Variation
13
Molecular Docking Studies; Dietary Compounds As HIV 1 Protease Inhibitors
16
Multi step inhibition explains HIV 1 protease inhibitor pharmacodynamics and resistance
14
Effects of HIV-1 protease on cellular functions and their potential applications in antiretroviral therapy
8
HIV-1 Protease Evolvability Is Affected by Synonymous Nucleotide Recoding
11
Defining the level of human immunodeficiency virus type 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivity.
8
HIV 1 protease induced apoptosis
15
Human immunodeficiency virus type 1 (HIV-1) protein Vif inhibits the activity of HIV-1 protease in bacteria and in vitro.
8
HIV 1 protease inhibitor mutations affect the development of HIV 1 resistance to the maturation inhibitor bevirimat
12
Generation and characterization of a human immunodeficiency virus type 1 (HIV-1) mutant resistant to an HIV-1 protease inhibitor.
7
HIV 1 protease cleaves the serine threonine kinases RIPK1 and RIPK2
16
The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?
9
Intracellular expression of human immunodeficiency virus type 1 (HIV-1) protease variants inhibits replication of wild-type and protease inhibitor-resistant HIV-1 strains in human T-cell lines.
8
Optimizing HIV-1 protease production in Escherichia coli as fusion protein
10
Virological Response to Highly Active Antiretroviral Therapy in Patients Infected with Human Immunodeficiency Virus Type 2 (HIV 2) and in Patients Dually Infected with HIV 1 and HIV 2 in The Gambia and Emergence of Drug Resistant Variants
9
BioAfrica's HIV 1 Proteomics Resource: Combining protein data with bioinformatics tools
14